Table 2.
Analysis of female prevalence comparison to male prevalence
| Symptom | Number of studies | Female sample size | Male sample size | Female prevalence | Male prevalence | Risk Ratio (95% CI) | p value |
|---|---|---|---|---|---|---|---|
| Fatigue | 10 | 3,247 | 3,397 | 1,246 (38.37%) | 912 (26.84%) | 1.40 (1.22–1.6) | <0.001 |
| Headache | 7 | 2,856 | 2,883 | 755 (26.43%) | 551 (19.81%) | 1.37 (1.12–1.67) | 0.002 |
| Anxeity | 5 | 2,569 | 3,008 | 340 (13.23%) | 318 (10.57%) | 1.32 (0.91–1.92) | 0.13 |
| Depression | 4 | 2,523 | 2,920 | 372 (14.74%) | 261 (8.93%) | 1.49 (1.2–1.86) | <0.001 |
| Brain-fog symptoms | 7 | 2,863 | 3,173 | 486 (16.9%) | 352 (11.09%) | 1.38 (1.08–1.76) | 0.011 |
| Post-traumic stress disorder | 1 | 137 | 240 | 42 (30.65%) | 43 (17.90%) | NE | NE |
| Anosmia | 5 | 2,563 | 2,993 | 313 (12.2%) | 200 (6.66%) | 1.61 (1.36–1.90) | <0.001 |
| Paresthesia | 2 | 1,458 | 1,611 | 43 (2.9%) | 40 (2.4%) | NE | NE |
| Dysgeusia | 2 | 1,444 | 1,789 | 141 (9.76%) | 102 (5.7%) | NE | NE |
| Vertigo | 2 | 1,458 | 1,611 | 64 (4.3%) | 60 (3.72%) | NE | NE |
| Visual Disturbances | 2 | 1,458 | 1,611 | 49 (3.3%) | 49 (3%) | NE | NE |
CI, Confidence interval; NE, non estimable.
Bold entries in the table idicate a p value of ≤0.05.